🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/01/2008 4,45 4,58 4,45 4,51 -0,44% 2,92% 758.600
03/01/2008 4,52 4,59 4,48 4,53 +0,22% 2,43% 743.200
02/01/2008 4,48 4,55 4,41 4,52 -0,44% 3,12% 1.107.500
31/12/2007 4,33 4,56 4,33 4,54 +0,89% 5,31% 781.100
28/12/2007 4,38 4,54 4,29 4,50 +3,21% 5,71% 1.013.700
27/12/2007 4,18 4,39 4,18 4,36 +4,06% 5,02% 1.122.300
26/12/2007 4,24 4,24 4,11 4,19 -1,18% 3,07% 1.101.300
24/12/2007 4,40 4,41 4,19 4,24 -3,64% 5,00% 911.100
21/12/2007 4,44 4,50 4,31 4,40 +0,46% 4,28% 1.149.500
20/12/2007 4,41 4,49 4,31 4,38 -0,45% 4,08% 1.258.800
19/12/2007 4,65 4,70 4,36 4,40 -6,18% 7,31% 1.364.500
18/12/2007 4,64 4,75 4,50 4,69 +2,40% 5,39% 1.182.400
17/12/2007 4,90 4,98 4,51 4,58 -6,34% 9,59% 1.737.500
14/12/2007 4,81 5,03 4,43 4,89 -6,86% 12,47% 5.023.500
13/12/2007 5,50 6,01 5,01 5,25 -48,78% 18,18% 15.587.000
12/12/2007 10,55 10,73 9,89 10,25 -1,25% 7,96% 1.946.100
11/12/2007 10,78 10,96 10,30 10,38 -3,71% 6,12% 1.222.500
10/12/2007 11,75 11,88 10,65 10,78 -6,26% 10,47% 1.018.600
07/12/2007 11,95 12,00 11,42 11,50 -3,04% 4,85% 886.600
06/12/2007 11,66 12,24 11,59 11,86 +1,19% 5,57% 984.900
05/12/2007 12,02 12,25 11,32 11,72 -1,51% 7,74% 936.200
04/12/2007 12,87 12,87 11,71 11,90 -7,25% 9,01% 1.598.000
03/12/2007 13,07 13,07 12,69 12,83 -1,46% 2,91% 930.100
30/11/2007 12,06 13,05 12,06 13,02 +8,59% 8,21% 1.379.200
29/11/2007 10,77 12,94 10,77 11,99 +11,74% 20,15% 2.762.800
28/11/2007 10,33 10,98 10,19 10,73 +4,58% 7,65% 1.226.900
27/11/2007 9,90 10,35 9,59 10,26 +3,74% 7,68% 798.000
26/11/2007 10,05 10,17 9,82 9,89 -1,69% 3,48% 427.300
23/11/2007 9,77 10,17 9,74 10,06 +3,60% 4,40% 309.600
21/11/2007 9,43 9,82 9,43 9,71 -0,31% 4,14% 566.100